K74.2 Hepatic fibrosis with hepatic sclerosis

Name of the Condition

• Hepatic Fibrosis with Hepatic Sclerosis

Summary

Hepatic fibrosis with hepatic sclerosis is a condition characterized by the progressive scarring of liver tissue, leading to impaired liver function. This code specifically denotes the presence of both fibrosis (early scarring) and sclerosis (advanced scarring), indicating significant liver damage. The condition results from chronic liver injury and inflammation, which over time replace healthy liver cells with scar tissue, reducing the liver's ability to perform essential functions.

Causes

Hepatic fibrosis with hepatic sclerosis typically develops as a response to ongoing liver damage. Common triggers include chronic viral hepatitis (e.g., hepatitis B or C), long-term alcohol use, non-alcoholic fatty liver disease (NAFLD), and autoimmune liver conditions. Prolonged exposure to toxins, certain medications, or biliary tract diseases may also contribute to the progression of scarring.

Risk Factors

• Chronic viral hepatitis infections
• Excessive alcohol consumption
• Obesity and metabolic syndrome
• Type 2 diabetes
• High cholesterol or triglycerides
• Genetic predispositions to liver disease
• Prolonged exposure to toxins or medications

Symptoms

• Fatigue and weakness
• Jaundice (yellowing of skin or eyes)
• Itchy skin
• Easy bruising or bleeding
• Swelling in legs or abdomen (edema/ascites)
• Abdominal pain or discomfort
• Loss of appetite or weight loss

Diagnosis

Diagnosis involves a combination of clinical evaluation and testing. Blood tests assess liver function and markers of inflammation or damage. Imaging studies, such as ultrasound, CT, or MRI, may reveal liver scarring or changes in texture. A liver biopsy is often performed to confirm the extent of fibrosis and sclerosis and to rule out other conditions.

Treatment Options

Treatment focuses on addressing the underlying cause of liver damage to slow or halt progression. This may include antiviral medications for hepatitis, lifestyle modifications (e.g., alcohol cessation, weight management), and management of metabolic conditions. In advanced cases, liver transplantation may be considered.

Prognosis and Follow-Up

The prognosis depends on the underlying cause, the extent of liver damage, and the effectiveness of treatment. Early intervention can slow progression, but advanced sclerosis may lead to irreversible liver dysfunction. Regular follow-up with liver function tests and imaging is essential to monitor disease activity and adjust treatment as needed.

Complications

• Liver failure
• Portal hypertension (increased blood pressure in the liver's veins)
• Esophageal varices (enlarged veins in the esophagus)
• Ascites (fluid buildup in the abdomen)
• Hepatic encephalopathy (brain function decline due to liver failure)
• Increased risk of liver cancer

Lifestyle & Prevention

• Limit alcohol consumption or avoid it entirely
• Maintain a healthy weight and manage metabolic conditions
• Get vaccinated against hepatitis A and B
• Avoid exposure to toxins or unnecessary medications
• Follow a balanced diet and exercise regularly
• Monitor and manage chronic conditions like diabetes or high cholesterol

When to Seek Professional Help

Seek medical attention if you experience persistent fatigue, jaundice, unexplained weight loss, abdominal swelling, or signs of bleeding (e.g., easy bruising). Early evaluation is critical for managing underlying causes and preventing further liver damage.

Tips for Medical Coders

When coding for hepatic fibrosis with hepatic sclerosis (K74.2), ensure documentation supports the presence of both fibrosis and sclerosis. Verify that the underlying cause, if known, is not separately coded unless explicitly required. Review clinical notes for evidence of liver damage progression and associated complications to ensure accurate code assignment.